Q: What is Atripla used for?

Atripla is used to treat HIV-1 infection .

Q: How does Atripla work?

Mechanism of Action Atripla is a combination of three antiretroviral medications: efavirenz, emtricitabine, and tenofovir disoproxil fumarate. These medications work together to prevent HIV from multiplying in the body. The virus requires a specific enzyme called reverse transcriptase to create copies of itself. Atripla targets this enzyme to stop the viral replication process. The three components work in the following ways: Efavirenz: This is a non-nucleoside reverse transcriptase inhibitor (NNRTI). It binds directly to the enzyme to prevent it from functioning properly. Emtricitabine and Tenofovir: These are nucleoside reverse transcriptase inhibitors (NRTIs). They act as faulty building blocks that the virus tries to use to create its DNA. When the virus incorporates these instead of normal building blocks, the DNA chain is broken, and the virus cannot finish copying itself. By lowering the amount of HIV in the blood, Atripla helps the immune system function better. This increases the body's ability to fight off other infections and reduces the risk of complications related to HIV. While Atripla helps manage the condition, it does not cure HIV or AIDS and must be taken consistently to remain effective.

Q: What are the active ingredients in Atripla?

The active ingredients in Atripla are efavirenz , emtricitabine , and tenofovir disoproxil .

Q: What are the side effects of Atripla?

Common side effects of Atripla may include: dizziness abnormal dreams diarrhea and others Always consult with a healthcare professional about potential side effects.

Q: What is the dosage of Atripla and how do I take it?

How to Take Atripla Atripla is taken by mouth as a single tablet. It is generally prescribed to be taken once a day. For the medication to be absorbed correctly and to reduce the risk of side effects, it should be taken on an empty stomach. Taking the dose at bedtime may help minimize certain side effects, such as dizziness or trouble concentrating. When taking this medication, follow these instructions: Swallow the tablet whole with water. Do not crush, chew, or break the tablet. Try to take the medication at the same time every day to maintain a steady level of the drug in your system. Continue taking the medication even if you feel well. Do not skip doses or stop taking the medication without consulting a healthcare provider, as this can make the virus more difficult to treat. Missed Doses If you miss a dose of Atripla, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and return to your regular schedule. Do not take two doses at once to make up for a missed one.

Q: Is Atripla safe during pregnancy and breastfeeding?

Pregnancy The use of Atripla during pregnancy involves several considerations. One of its components, efavirenz, has been associated with a risk of birth defects when used during the first trimester. Because of this, healthcare providers often recommend using effective contraception while taking this medication and for several weeks after stopping it. If you become pregnant while taking Atripla, it is important to contact a healthcare provider immediately. They will help determine if the medication should be continued or if a different treatment plan is necessary. Maintaining control of the HIV infection is vital for the health of the parent and to reduce the risk of transmitting the virus to the baby. Breastfeeding In general, health authorities recommend that people with HIV do not breastfeed their infants. This recommendation is intended to prevent the transmission of HIV to the baby through breast milk. Furthermore, the medications in Atripla can pass into breast milk, and their safety for nursing infants has not been fully established.

Q: What is the FDA approval status of Atripla?

FDA Approval Status The U.S. Food and Drug Administration (FDA) approved Atripla in July 2006. It was the first once-daily medication to combine three different antiretroviral drugs into a single tablet for the treatment of HIV-1 infection. It is approved for use in adults and pediatric patients weighing at least 40 kg. Boxed Warnings Atripla carries a boxed warning, which is the most serious warning required by the FDA. These warnings include: Lactic Acidosis and Liver Toxicity: There is a risk of lactic acidosis (a buildup of acid in the blood) and severe liver enlargement with fatty deposits (hepatomegaly with steatosis). These conditions can be life-threatening. Hepatitis B Virus (HBV) Exacerbation: Atripla is not approved to treat chronic HBV infection. Patients with both HIV-1 and HBV may experience a severe worsening of their hepatitis B if they stop taking Atripla. The FDA recommends that these patients have their liver function monitored closely for several months after stopping the drug. Prescription and Safety Information Atripla is available only by prescription. The FDA requires that a Medication Guide be provided to patients with each prescription to explain the risks and proper use of the medication. It does not currently require a Risk Evaluation and Mitigation Strategy (REMS) program.

Question 1

What is Atripla?

Accepted Answer

Atripla is a combination medication that contains efavirenz, emtricitabine, and tenofovir disoproxil fumarate. It is primarily used in the management of human immunodeficiency virus (HIV) infection. By combining three antiretroviral agents, Atripla helps to suppress the replication of the virus in the body. This medication is commonly associated with the long-term control of HIV in adults and adolescents.

Question 2

What is Atripla used for?

Accepted Answer

Atripla is used to treat HIV-1 infection.

Question 3

How does Atripla work?

Accepted Answer

Mechanism of Action

Atripla is a combination of three antiretroviral medications: efavirenz, emtricitabine, and tenofovir disoproxil fumarate. These medications work together to prevent HIV from multiplying in the body.

The virus requires a specific enzyme called reverse transcriptase to create copies of itself. Atripla targets this enzyme to stop the viral replication process. The three components work in the following ways:

Efavirenz: This is a non-nucleoside reverse transcriptase inhibitor (NNRTI). It binds directly to the enzyme to prevent it from functioning properly.
Emtricitabine and Tenofovir: These are nucleoside reverse transcriptase inhibitors (NRTIs). They act as faulty building blocks that the virus tries to use to create its DNA. When the virus incorporates these instead of normal building blocks, the DNA chain is broken, and the virus cannot finish copying itself.

By lowering the amount of HIV in the blood, Atripla helps the immune system function better. This increases the body's ability to fight off other infections and reduces the risk of complications related to HIV. While Atripla helps manage the condition, it does not cure HIV or AIDS and must be taken consistently to remain effective.

Question 4

What are the active ingredients in Atripla?

Accepted Answer

The active ingredients in Atripla are efavirenz, emtricitabine, and tenofovir disoproxil.

Question 5

What are the side effects of Atripla?

Accepted Answer

Common side effects of Atripla may include:

dizziness
abnormal dreams
diarrhea
and others

Always consult with a healthcare professional about potential side effects.

Question 6

What drug class is Atripla?

Accepted Answer

Atripla belongs to the antiretroviral combination drug class.

Question 7

What is the dosage of Atripla and how do I take it?

Accepted Answer

How to Take Atripla

Atripla is taken by mouth as a single tablet. It is generally prescribed to be taken once a day. For the medication to be absorbed correctly and to reduce the risk of side effects, it should be taken on an empty stomach. Taking the dose at bedtime may help minimize certain side effects, such as dizziness or trouble concentrating.

When taking this medication, follow these instructions:

Swallow the tablet whole with water. Do not crush, chew, or break the tablet.
Try to take the medication at the same time every day to maintain a steady level of the drug in your system.
Continue taking the medication even if you feel well. Do not skip doses or stop taking the medication without consulting a healthcare provider, as this can make the virus more difficult to treat.

Missed Doses

If you miss a dose of Atripla, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and return to your regular schedule. Do not take two doses at once to make up for a missed one.

Question 8

Is Atripla safe during pregnancy and breastfeeding?

Accepted Answer

Pregnancy

The use of Atripla during pregnancy involves several considerations. One of its components, efavirenz, has been associated with a risk of birth defects when used during the first trimester. Because of this, healthcare providers often recommend using effective contraception while taking this medication and for several weeks after stopping it.

If you become pregnant while taking Atripla, it is important to contact a healthcare provider immediately. They will help determine if the medication should be continued or if a different treatment plan is necessary. Maintaining control of the HIV infection is vital for the health of the parent and to reduce the risk of transmitting the virus to the baby.

Breastfeeding

In general, health authorities recommend that people with HIV do not breastfeed their infants. This recommendation is intended to prevent the transmission of HIV to the baby through breast milk. Furthermore, the medications in Atripla can pass into breast milk, and their safety for nursing infants has not been fully established.

Question 9

What forms and strengths does Atripla come in?

Accepted Answer

Atripla is supplied as a film-coated tablet. This medication is a combination product intended for oral use.

Tablet

Question 10

What is the FDA approval status of Atripla?

Accepted Answer

FDA Approval Status

The U.S. Food and Drug Administration (FDA) approved Atripla in July 2006. It was the first once-daily medication to combine three different antiretroviral drugs into a single tablet for the treatment of HIV-1 infection. It is approved for use in adults and pediatric patients weighing at least 40 kg.

Boxed Warnings

Atripla carries a boxed warning, which is the most serious warning required by the FDA. These warnings include:

Lactic Acidosis and Liver Toxicity: There is a risk of lactic acidosis (a buildup of acid in the blood) and severe liver enlargement with fatty deposits (hepatomegaly with steatosis). These conditions can be life-threatening.
Hepatitis B Virus (HBV) Exacerbation: Atripla is not approved to treat chronic HBV infection. Patients with both HIV-1 and HBV may experience a severe worsening of their hepatitis B if they stop taking Atripla. The FDA recommends that these patients have their liver function monitored closely for several months after stopping the drug.

Prescription and Safety Information

Atripla is available only by prescription. The FDA requires that a Medication Guide be provided to patients with each prescription to explain the risks and proper use of the medication. It does not currently require a Risk Evaluation and Mitigation Strategy (REMS) program.

Question 11

What should I know about Atripla and cost?

Accepted Answer

Factors Influencing Cost

The price of Atripla can vary significantly based on several factors. Generic versions of the combination of efavirenz, emtricitabine, and tenofovir disoproxil fumarate are available and are generally more affordable than the brand-name drug.

Other factors that affect the cost include:

Insurance coverage: Most commercial insurance plans, Medicare, and Medicaid cover this medication, though out-of-pocket costs like copays and deductibles will vary by plan.
Pharmacy selection: Costs may differ between local retail pharmacies and mail-order pharmacy services.

Financial Assistance

Financial support may be available for those who have difficulty affording the medication:

Patient Assistance Programs: Manufacturers often offer programs to provide medications at low or no cost to individuals who meet certain income and eligibility criteria.
Co-pay Cards: Some patients with private insurance may qualify for savings cards that reduce their monthly out-of-pocket expenses.
Government Programs: The AIDS Drug Assistance Program (ADAP) is a state-run program that helps eligible individuals access HIV treatments.

Atripla

📋Overview

How It Works

Uses

Active Ingredients

Common Side Effects

Warnings & Precautions

Dosage

Pregnancy & Breastfeeding

Frequently Asked Questions

📚References

Found an Error?

Find Discounts for Atripla

Hospitals.net Disclosure